This report represents an analysis of 19 confirmed cases of breast cancer throughout a period of 14 months (January 2018 - February 2019), in which we assessed the incidence and sites of osseous metastases, in correlation with their histopathologic classification. This retrospective analysis is based on medical imaging techniques (X-ray radiography and nuclear medicine functional imaging).
2. van Zijl F Krupitza G Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutation Research/Reviews in Mutation Research. 2011; 728:(1-2)23-3.
3. Chambers AF Groom AC MacDonald IC. Metastasis: dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer. 2002; 2(8)563.
4. Klein CA. Parallel progression of primary tumours and metastases. Nature Reviews Cancer. 2009; 9(4)302.
5. McPherson K Steel C Dixon JM. ABC of breast diseases: breast cancer—epidemiology risk factors and genetics. BMJ: British Medical Journal. 2000; 321(7261)624.
6. Abrams HL. Skeletal metastases in carcinoma. Radiology. 1950; 55:534–5383.
7. Rivkees A Crawford J. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAm Med Assoc. 1988; 259:2123-5.
8. Saarto T et al. Chemical castration induced by adjuvant cyclophosphamide methotrexate and fluorouracil chemotherapy causes rapid bone loss that is reduced by c1odronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol. 1997; 15:1341-7.
9. Powles T et al. The effect of tamoxifen on lumbar bone mineral density in pre- and post-menopausal women. J Clin Oncol. 1996; 14:78-84.